Allergan India Private Limited, a joint venture between Allergan Inc., and Nicholas Piramal India Limited, commenced commercial operations in 1996. Allergan India is a specialty pharmaceutical company. It has emerged as the market leader in the fast growing ophthalmic category with the successful launches of a series of high technology solutions and drugs for diseases such as glaucoma, dry eye and various other eye-infections and inflammations. Allergan India is today the partner of choice for majority of the eye-specialists in the country. With sales of Rs. 140+ crores and a strong organization, Allergan India is poised to grow at a rapid pace.
Allergan Inc., a Fortune 1000 company (2007 Rank #644 amongst US based companies) in the US with headquarters in Irvine, California, is an innovative, technology driven, global health care company that develops and commercializes specialty pharmaceutical & healthcare products that deliver value to its customers, satisfy unmet medical needs and continually improve patient’s lives. With reported revenues of $4.5 bn in ’09 and a significant investment of $700 mn in R&D, Allergan currently operates in over 101 countries worldwide. Allergan markets products that deliver value to its customers, satisfy unmet medical needs and improve patients’ lives.
Founded in 1948, Allergan employs more than 6,000 colleagues worldwide. Allergan is a pioneer in specialty pharmaceutical research, with a strong pipeline of products and technologies related to specific disease areas such as glaucoma, retinal disease, cataracts, dry eye, pain, movement disorders.
Allergan Inc is known for its operational excellence and for the very same reason; Forbes has listed Allergan Inc as the best managed company in the drugs and Biotechnology segment in the US.